Journals / Tüberküloz ve Toraks / 2016 / Cilt: 64 - Sayı: 3

Sepsis nedeniyle yoğun bakıma alınan hastalarda adrenal yetmezlik varlığında adrenomedullin mortalite ilişkisi

Level of adrenomedullin in cases with adrenal defficiency and its relation to mortality in patients with sepsis

Pages
191–197
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Without evaluation of adrenal function adrenomedullin should not be used, in predicting mortality of sepsis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: The aim of this study was to determine the prognostic value of adrenomedullin, after evaluation of adrenal function in sepsis patients.
📊
Key Findings & Data:We enrolled 48 patients, who were admitted to the intensive care unit due to sepsis according to surviving sepsis campaign criteria.
💡
Conclusion & Impact:Conclusion: Without evaluation of adrenal function adrenomedullin should not be used, in predicting mortality of sepsis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: The aim of this study was to determine the prognostic value of adrenomedullin, after evaluation of adrenal function in sepsis patients. We also evaluated other prognostic factors such as APACHE II score, proBNP, and CRP and their prediction in mortality. Materials and Methods: This is a prospective, observational study. We enrolled 48 patients, who were admitted to the intensive care unit due to sepsis according to surviving sepsis campaign criteria. Results: ADM median value was 60.8 ng/L in patients with normal adrenal function, and 20.1 ng/L in patients who had adrenal deficiency. With adequate adrenal response there was a linear and statistically significant relationship between adrenomedullin and mortality (p 30.19 ng/L (sensitivity: 73.0%, specificity: 100%), APACHE II score was > 21 (sensitivity: 93.3%, specificity: 84.8%), and proBNP > 3736 pg/mL (sensitivity: 73.3%, specificity: 93.9%). Conclusion: Without evaluation of adrenal function adrenomedullin should not be used, in predicting mortality of sepsis.

Özet

Giriş: Bu çalışmanın amacı, sepsis hastalarında adrenal fonksiyonu değerlendirdikten sonra adrenomedullin ile mortalite arasında ilişki kurmaktır. Bunun yanında APACHE II skoru, proBNP ve C-reaktif protein (CRP) gibi diğer markerlar ile mortalite arasındaki ilişki değerlendirilmiştir.Bulgular: Median adrenomedüllin (ADM) değeri adrenal yanıtı tam olan hastalarda 60.8 ng/L olarak bulunmuş, adrenal yetmezlikli hastalarda 20.1 ng/L olarak tespit edilmiştir. Yeterli adrenal yanıtın olduğu hastalarda adrenomedullin ile mortalite arasında doğrusal ve anlamlı bir ilişki tespit edilmiştir (p 30.19 ng/L, APACHE II skoru > 21 ve proBNP > 3736 pg/mL olan hastalarda mortalitenin anlamlı ölçüde yüksek olduğu tespit edilmiştir.Sonuç: Hastalarda mortalite ve adrenomedullin arasında ilişki kurmadan önce adrenal fonksiyonun yeterli olup olmadığı değerlendirilmelidir

🔖

Cite This Article

BALCAN, B., AKBAŞ, T., ERYÜKSEL, E., KARAKURT, S., OLGUN, Ş. (2022). Sepsis nedeniyle yoğun bakıma alınan hastalarda adrenal yetmezlik varlığında adrenomedullin mortalite ilişkisi. Tüberküloz ve Toraks, Cilt: 64 - Sayı: 3, 191–197. https://ajindex.com/articles/618528

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Dellinger RP. The surviving sepsis campaign: 2013 and beyond. Chin Med J 2013;126:1803-5. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420:885-91. Kitamura K. [adrenomedullin and related peptides]. Nihon yakurigaku zasshi. Folia Pharmacologica Japonica 1998;112:137-46.
  2. Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000;21:138- 67. Ehlenz K, Koch B, Preuss P, Simon B, Koop I, Lang RE. High levels of circulating adrenomedullin in severe illness: Correlation with C-reactive protein and evidence against the adrenal medulla as site of origin. Exp Clin Endocrinol Diabetes 1997;105:156-62.
  3. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, et al. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996;81:1449- 53. Nishio K, Akai Y, Murao Y, Doi N, Ueda S, Tabuse H, et al. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 1997;25:953-7.
  4. Debiane L, Hachem RY, Al Wohoush I, Shomali W, Bahu RR, Jiang Y, et al. The utility of proadrenomedullin and procalcitonin in comparison to c-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer. Crit Care Med 2014;42:2500-7.
  5. Jordan I, Corniero P, Balaguer M, Ortiz J, Vila D, Velasco J, et al. Adrenomedullin is a useful biomarker for the prognosis of critically ill septic children. Biomark Med 2014;8:1065-72.
  6. Suberviola B, Castellanos-Ortega A, Ruiz Ruiz A, Lopez- Hoyos M, Santibanez M. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Med 2013;39:1945-52.
  7. Angeletti S, Battistoni F, Fioravanti M, Bernardini S, Dicuonzo G. Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis. Clin Chem Lab Med CCLM/ FESCC 2013;51:1059-67.
  8. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, et al. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci Lett 1996;203:207-10.
  9. Kapas S, Martinez A, Cuttitta F, Hinson JP. Local production and action of adrenomedullin in the rat adrenal zona glomerulosa. J Endocrinol 1998;156:477-84.
  10. Vogt S, Winkler E, Hermsen D, Schott M, Schinner S, Scherbaum WA, et al. Endothelin-1 and adrenomedullin plasma levels after exposure to fludrocortisone, dexa